Keep the quality high: the benefits of lot testing for the quality control of malaria rapid diagnostic tests - Archive ouverte HAL Access content directly
Journal Articles Malaria Journal Year : 2020

## Keep the quality high: the benefits of lot testing for the quality control of malaria rapid diagnostic tests

(1) , , (1) , (2) , (3, 4) , (5) , (6) , (6) , (7) , (8) , (6) , (9) , (1) , (1, 10) , (1)
1
2
3
4
5
6
7
8
9
10
Sandra Incardona
• Function : Correspondent author
• PersonId : 1103798

Connectez-vous pour contacter l'auteur
David Bell
• Function : Author
Ana Campillo
• Function : Author
Jane Cunningham
• Function : Author
Thierry Fandeur
• Function : Author
Didier Menard
Benoit Witkowski
• Function : Author
• PersonId : 751218
• IdHAL : bwitkowski
Zachary Katz
• Function : Author
Xavier C. Ding
• Function : Author

#### Abstract

Background The production and use of malaria rapid diagnostic tests (RDTs) has risen dramatically over the past 20 years. In view of weak or non-existing in vitro diagnostics (IVD) regulations and post-marketing surveillance (PMS) systems in malaria endemic countries, the World Health Organization, later joined by the Foundation for Innovative New Diagnostics, established an independent, centralized performance evaluation and Lot Testing (LT) programme to safeguard against poor quality of RDTs being distributed through the public health sector of malaria endemic countries. RDT performances and manufacturer quality management systems have evolved over the past decade raising questions about the future need for a centralized LT programme. Results Between 2007 and 2017, 6056 lots have been evaluated, representing approximately 1.6 Billion RDTs. A total of 69 lots (1.1%) failed the quality control. Of these failures, 26 were detected at receipt of the RDT lot in the LT laboratory, representing an estimated 7.9 million poor quality RDTs, and LT requesters were advised that RDTs were not of sufficient quality for use in patient management. Forty-three were detected after long-term storage in the laboratory, of which 24 (56%) were found to be due to a major issue with insufficient buffer volume in single use buffer vials, others predominantly showing loss of sensitivity. The annual cost of running the programme, based on expenses recorded in years 2014–2016, an estimated volume of 700 lots per year and including replenishment of quality control samples, was estimated at US$178,500 ($US 255 per lot tested). Conclusions Despite the clear benefits of the centralized LT programme and its low cost compared with the potential costs of each country establishing its own PMS system for RDTs, funding concerns have made its future beyond 2020 uncertain. In order to manage the risks of misdiagnosis due to low quality RDTs, and to ensure the continued safety and reliability of malaria case management, there is a need to ensure that an effective and implementable approach to RDT quality control continues to be available to programmes in endemic countries.

### Dates and versions

pasteur-03274278 , version 1 (29-06-2021)

### Identifiers

• HAL Id : pasteur-03274278 , version 1
• DOI :
• PUBMED :
• PUBMEDCENTRAL :

### Cite

Sandra Incardona, David Bell, Ana Campillo, Jane Cunningham, Frederic Ariey, et al.. Keep the quality high: the benefits of lot testing for the quality control of malaria rapid diagnostic tests. Malaria Journal, 2020, 19 (1), pp.247. ⟨10.1186/s12936-020-03324-3⟩. ⟨pasteur-03274278⟩

### Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

17 View